These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17653204)

  • 1. Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?
    Matrisciano F; Panaccione I; Zusso M; Giusti P; Tatarelli R; Iacovelli L; Mathé AA; Gruber SH; Nicoletti F; Girardi P
    Mol Psychiatry; 2007 Aug; 12(8):704-6. PubMed ID: 17653204
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands.
    Matrisciano F; Scaccianoce S; Del Bianco P; Panaccione I; Canudas AM; Battaglia G; Riozzi B; Ngomba RT; Molinaro G; Tatarelli R; Melchiorri D; Nicoletti F
    J Neurochem; 2005 Jun; 93(5):1345-52. PubMed ID: 15934953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats.
    Matrisciano F; Caruso A; Orlando R; Marchiafava M; Bruno V; Battaglia G; Gruber SH; Melchiorri D; Tatarelli R; Girardi P; Mathè AA; Nicoletti F
    Neuropharmacology; 2008 Sep; 55(4):525-31. PubMed ID: 18590921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of imipramine treatment on the group I of metabotropic glutamate receptors in CA1 region of hippocampus.
    Pałucha A; Brański P; Tokarski K; Bijak M; Pilc A
    Pol J Pharmacol; 1997; 49(6):495-7. PubMed ID: 9566055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic antidepressant or electroconvulsive shock treatment on mGLuR1a immunoreactivity expression in the rat hippocampus.
    Bajkowska M; Brański P; Smiałowska M; Pilc A
    Pol J Pharmacol; 1999; 51(6):539-41. PubMed ID: 10817534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action.
    Podkowa K; Rzeźniczek S; Marciniak M; Acher F; Pilc A; Pałucha-Poniewiera A
    Neuropharmacology; 2015 Oct; 97():338-45. PubMed ID: 26074092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
    Lorrain DS; Schaffhauser H; Campbell UC; Baccei CS; Correa LD; Rowe B; Rodriguez DE; Anderson JJ; Varney MA; Pinkerton AB; Vernier JM; Bristow LJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1622-32. PubMed ID: 12825094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
    Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
    Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine-induced subsensitivity to the 5-HT4 receptor activation, a possible mediation via an alteration in the postreceptor transduction mechanism involving adenylate cyclase.
    Bijak M
    Pol J Pharmacol; 1997; 49(5):345-50. PubMed ID: 9566034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
    Réus GZ; Stringari RB; Kirsch TR; Fries GR; Kapczinski F; Roesler R; Quevedo J
    Brain Res Bull; 2010 Apr; 81(6):585-9. PubMed ID: 19954760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal astrocytes are necessary for antidepressant treatment of learned helplessness rats.
    Iwata M; Shirayama Y; Ishida H; Hazama GI; Nakagome K
    Hippocampus; 2011 Aug; 21(8):877-84. PubMed ID: 20572198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct properties of presynaptic group II and III metabotropic glutamate receptor-mediated inhibition of perforant pathway-CA1 EPSCs.
    Capogna M
    Eur J Neurosci; 2004 May; 19(10):2847-58. PubMed ID: 15147318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration.
    Maciejak P; Szyndler J; Turzyńska D; Sobolewska A; Taracha E; Skórzewska A; Lehner M; Bidziński A; Hamed A; Wisłowska-Stanek A; Płaźnik A
    Brain Res; 2009 Jul; 1282():20-7. PubMed ID: 19481536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic inhibition of corticothalamic feedback by metabotropic glutamate receptors.
    Alexander GM; Godwin DW
    J Neurophysiol; 2005 Jul; 94(1):163-75. PubMed ID: 15772234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric drugs. Excited by glutamate.
    Holden C
    Science; 2003 Jun; 300(5627):1866-8. PubMed ID: 12817119
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subchronic treatment with imipramine ameliorates the decreased number in neuropeptide Y-positive cells in the hippocampus of learned helplessness rats.
    Ishida H; Shirayama Y; Iwata M; Kawahara R
    Brain Res; 2005 Jun; 1046(1-2):239-43. PubMed ID: 15869748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipramine treatment ameliorates corticosterone-induced alterations in the effects of 5-HT1A and 5-HT4 receptor activation in the CA1 area of rat hippocampus.
    Zahorodna A; Tokarski K; Hess G
    Eur Neuropsychopharmacol; 2006 Jul; 16(5):383-90. PubMed ID: 16380238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors.
    Kawashima N; Karasawa J; Shimazaki T; Chaki S; Okuyama S; Yasuhara A; Nakazato A
    Neurosci Lett; 2005 Apr; 378(3):131-4. PubMed ID: 15781145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.